| Structure |
Chemical Name |
CAS |
MF |
 |
Cetrorelix Impurity 4 (8-D-Arg) |
|
|
![2-Naphthalenamine, N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-[tris(1-methylethyl)silyl]ethynyl]-](/CAS/20210305/GIF/2816821-08-4.gif) |
2-Naphthalenamine, N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-[tris(1-methylethyl)silyl]ethynyl]- |
2816821-08-4 |
C40H47BFNO2Si |
|
|
Oseltamivir Impurity 77 |
|
|
 |
4-(3-ブロモプロピル)モルホリン |
125422-83-5 |
C7H14BrNO |
 |
4-N-Desacetyl-5-N-acetyl OseltaMivir |
956267-10-0 |
C16H28N2O4 |
 |
Solifenacin impurity 19 |
1422505-78-9 |
C17H17NO |
 |
GPZGXSFHPLUMHE-KEUNHQLVSA-N |
157054-84-7 |
C52H81NO13 |
![Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester](/CAS/20210305/GIF/2267259-70-9.gif) |
Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester |
2267259-70-9 |
C17H17NO10S2 |
|
|
Regorafenib Impurity 17 |
|
|
 |
3-モノクロロトリヨードチロニン |
909279-46-5 |
C15H11ClI3NO4 |
|
|
Tadalafil impurity R |
|
|
 |
ヘルバセチン-3,8-ジグルコピラノシド |
99224-12-1 |
C27H30O17 |
 |
Cefazolin Impurity 13 |
1607841-65-5 |
C25H24N12O6S6 |
 |
(3S,5S)-アトルバスタチンアセトニドTERT-ブチルチルエステル |
472967-95-6 |
C40H47FN2O5 |
|
|
Ceftazidime Impurity D |
|
|
 |
(S)-BoroLeu-(-)-Pinanediol-hydrochloride |
945606-99-5 |
C15H29BClNO2 |
 |
6-chloro-N-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5- nitro-2-(propylthio)pyrimidin-4-amine |
1427523-93-0 |
C16H15ClF2N4O2S |
 |
(2-broMo-4,5-diMethylphenyl)Methanol |
1126385-20-3 |
C9H11BrO |
|
|
Isavuconazole Impurity 7 |
|
|
 |
Nemonoxacin Impurity 5 |
2770004-79-8 |
C24H29N3O8 |
|
|
Dapoxetine Impurity C |
|
|
|
|
Cabozantinib impurity 25 |
|
|
 |
N-(2-Succinyl) Fluvoxamine |
259526-43-7 |
C19H25F3N2O6 |
 |
Cefotiam Impurity 22 |
1628441-07-5 |
C13H14N4O5S2 |
 |
4-Hydroxyisophthalonitrile |
34133-58-9 |
C8H4N2O |
 |
Metoprolol IMpurity 3 |
|
C15H25NO3 |
 |
1-(7,8-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride |
1822601-94-4 |
C12H15N |
|
|
Vildagliptin Impurity 33 |
|
|
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide](/CAS/GIF/957470-58-5.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide |
957470-58-5 |
C24H24F2N4O5S |
|
|
Ipragliflozin Impurity 1 |
|
|
|
|
Flucloxacillin IMpurity F |
|
|
|
|
Semaglutide Impurity 9 (L-2-Oxohistidine) |
|
|
|
|
Minoxidil Impurity G |
|
|
 |
N-メチル-4-(3,4-ジクロロフェニル)テトラリン-1-アミン |
140631-53-4 |
C17H17Cl2N |
 |
テルブタリン3,5-ジベンジルエーテル |
28924-25-6 |
C26H31NO3 |
|
|
Itraconazole iMpurity D |
|
|
 |
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
 |
Bis(aminoethoxy) Amlodipine |
721958-74-3 |
C22H30ClN3O6 |
|
|
Isavuconazole Impurity 44 |
|
|
 |
Metoprolol Impurity 1 |
|
C15H25NO3 |
![methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/57430-34-9.gif) |
methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
57430-34-9 |
C22H28N2O4 |
![6-Cyclopropyl-10-fluorobenzo[k]phenanthridine](/CAS/20180601/GIF/1187966-95-5.gif) |
6-Cyclopropyl-10-fluorobenzo[k]phenanthridine |
1187966-95-5 |
C20H14FN |
 |
(S)-(-)-3-(アセチルチオ)イソ酪酸 |
76497-39-7 |
C6H10O3S |
 |
methyl 3-(4-(3-(ethylamino)-2-hydroxypropoxy)phenyl)propanoate hydrochloride |
|
C15H24ClNO4 |
|
|
RocuroniuMbroMide iMpurity F |
|
|
 |
3-アミノ-4-ピラゾールカルボニトリル |
16617-46-2 |
C4H4N4 |
 |
4-(2-メチル-4,5-ジオキソイミダゾリジン-1-イル)-2,2-ジフェニルブタンアミド |
503598-05-8 |
C20H21N3O3 |
 |
Entecavir Impurity 5 |
84868-56-4 |
C21H20O2 |
![(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル](/CAS/20150408/GIF/204254-94-4.gif) |
(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル |
204254-94-4 |
C15H26O7S |
 |
3-Morpholinone, 4-(2,4-diaMinophenyl)- |
482308-13-4 |
C10H13N3O2 |
|
|
Erlotinib hydrochloride Impurity C |
|
|
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
 |
Apremilast |
1384967-20-7 |
C20H20N2O7S |
 |
10-メトキシ-6-メチルエルゴリン-8β-メタノール |
35121-60-9 |
C17H22N2O2 |
 |
ニコチン酸2-アミノエチルエステル二塩酸塩 |
87330-70-9 |
C8H11ClN2O2 |
|
|
Linagliptin Impurity A |
|
|
|
|
Moxifloxacin Related Impurity 3 |
|
|
![Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione)](/CAS/20180808/GIF/216453-74-6.gif) |
Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) |
216453-74-6 |
C25H32O6 |
|
|
Plerixafor Impurity 4 |
|
|
|
|
Tadalafil EP impurity E |
|
|
![1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)-](/CAS/20180808/GIF/1229512-52-0.gif) |
1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1229512-52-0 |
C20H18F3N |
|
|
Dapagliflozin Impurity C |
|
|
 |
Cefuroxime Sodium EP Impurity G |
97232-98-9 |
C17H17N3O8S |
 |
Amifostine related impurities 2 |
17002-55-0 |
C8H21N3O |
 |
3-chloro-5-((1-((4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)benzonitrile |
1338225-98-1 |
C18H13ClF3N5O3 |
 |
RAC アトモキセチン塩酸塩 |
82857-40-7 |
C17H22ClNO |
 |
ethyl 3-(2,4-difluoro-3-methoxyphenyl)-3-oxopropanoate |
221221-12-1 |
C12H12F2O4 |
|
|
Canagliflozin Impurity 12 |
|
|
 |
N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate |
928325-82-0 |
C21H21N3O6S |
 |
Ramosetron Impurity 13 |
183613-77-6 |
C17H13N3O |
|
|
Tenofovir Impurity 39 |
|
|
 |
Ticagrelor Related Compound 38D-Tartrate |
2165881-71-8 |
C10H19NO4 |
 |
Azilsartan iMpurity O |
2171316-29-1 |
C23H19N3O4 |
|
|
Canagliflozin Impurity 50 |
|
|
|
|
Ceftazidime side chain Impurity |
|
|
 |
Avibactam Impurity 40 |
2089462-89-3 |
C15H20N2O3 |
 |
Palbociclib Impurity 9 |
2204368-66-9 |
C24H29N7O2 |
 |
Atorvastatin pyrrolidone lactone |
906552-19-0 |
C33H33FN2O5 |
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl-](/CAS/20150408/GIF/1415560-29-0.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl- |
1415560-29-0 |
C13H13Br2N3O |
 |
Ganciclovir EP Impurity H |
84222-50-4 |
C9H13N5O4 |
 |
Loratadine Impurity 4 |
|
C22H23ClN2O2 |
 |
Apremilast |
1384440-16-7 |
C19H20N2O6S |
|
|
Pramipexole Impurity 18 |
|
|
 |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
|
|
Riociguat IMpurtiy |
2920299-23-4 |
|
 |
2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl- 1,3-dioxan-4-yl)acetic acid |
775571-58-9 |
C9H15ClO4 |
 |
N-Boc-シタグリプチン |
486460-23-5 |
C21H23F6N5O3 |
|
|
Anastrozole Impurity 3 |
|
|
 |
クリシン 6-C-グルコシド 8-C-アラビノシド |
185145-34-0 |
C26H28O13 |
|
|
Mixture of Cefoxitin Impurity E&F |
|
|
|
|
Tacrolimus impurity D |
|
|
 |
L-ロイシン酸アシクロビル |
142963-69-7 |
C14H23ClN6O4 |
|
|
Perospirone Impurity 20 |
1002359-81-0 |
|
 |
(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-06-5 |
C24H21F2NO3 |
 |
6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole)) |
1365727-07-6 |
C27H26N2O2 |
![5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone](/CAS/20180808/GIF/72744-67-3.gif) |
5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone |
72744-67-3 |
C8H10N2O2S2 |
 |
Dasatinib iMpurity |
1184919-23-0 |
C22H27N7O2S |
 |
Acetonitrile, (3,4-dihydro-7-methoxy-1(2H)-naphthalenylidene)-, (Z)- (9CI) |
178676-66-9 |
C13H13NO |
 |
cis-cyclo(Pro-Pro) |
19943-27-2 |
C10H14N2O2 |
|
|
Formoterol Impurity 16 |
|
|